SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aurobindo Pharma inaugurates biologics contract manufacturing facility ‘TheraNym’

04 Jun 2026 Evaluate

Aurobindo Pharma has inaugurated TheraNym, one of India's largest dedicated biologics contract manufacturing organisations (CMO). TheraNym represents Aurobindo Pharma’s bold and strategic foray into biologics contract manufacturing - a segment that is growing worldwide and is increasingly vital to meeting global demand for biologic therapies.

The facility is strategically located in Borapatla approximately 45 minutes from the Hyderabad’s bustling Financial District and is equipped with 15 KL bioreactors, advanced downstream processing suites, aseptic fill-finish capabilities, and quality control laboratories. TheraNym has been designed with international regulatory expectations in mind. The facility is intended to support MSD supply chain, both domestic and export markets, subject to applicable approvals and customer requirements. 

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments. 


Aurobindo Pharma Share Price

1463.60 23.30 (1.62%)
04-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1779.35
Dr. Reddys Lab 1267.05
Cipla 1397.75
Zydus Lifesciences 1085.45
Lupin 2248.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×